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Hyphantria cunea nucleopolyhedrovirus (HycuNPV) infection protected SpIm cells from actinomycin D (ActD)-induced apoptosis as
early as 4 h postinfection. Analysis by Southern hybridization revealed that the HycuNPV genome possessed three members of inhibitor of
apoptosis genes (iaps) that were designated as hycu-iap1, hycu-iap2, and hycu-iap3 because of their amino acid sequence homology with
iaps identified in other baculoviruses. Functional analysis of Hycu-IAPs by transient expression assay in Sf9 cells revealed that Hycu-IAP3
blocked apoptosis induced by actinomycin D and rescued replication of p35 deficient-mutant AcMNPV, while Hycu-IAP1 and Hycu-IAP2
did not show any anti-apoptotic functions. Knockdown of hycu-iap3 expression by RNAi during HycuNPV infection in SpIm cells induced
apoptosis. These results indicate that Hycu-IAP3 is essential for blockage of apoptosis during HycuNPV infection of permissive SpIm cells.
D 2004 Elsevier Inc. All rights reserved.Keywords: Baculovirus; Nucleopolyhedrovirus; Hyphantria cunea; Apoptosis; Inhibitor of apoptosis; IAPIntroduction
Apoptosis is a genetically regulated cell death that func-
tions not only to eliminate unnecessary cells during normal
development and tissue turnover, but also as a cellular
defense mechanism against oncogene expression and virus
infection. In virus infection, apoptosis triggered early in
infection results in reduced production of progeny virions
and exclusion of the infected cells from the organism. To cope
with cellular antiviral mechanisms associated with apoptosis
induction, many viruses have evolved various genes whose
products are able to ablate the apoptotic pathway to maximize
their multiplication in infected cells (Everett and McFadden,
2001; Razvi and Welsh, 1995; Roulston et al., 1999; Teodoro
and Branton, 1997). In baculoviruses, two types of anti-
apoptotic genes, p35 and inhibitor of apoptosis (iap), have
been identified (Clem, 2001).
p35 homologues have been found in Autographa cal-
ifornica multicapsid nucleopolyhedrovirus (AcMNPV),0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.01.002
$ The DDBJ accession numbers of the hycu-iap1, hycu-iap2, and
hycu-iap3 sequences reported in this paper are AB088848, AB088849, and
AB088850, respectively.
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E-mail address: mochiko@agr.nagoya-u.ac.jp (M. Ikeda).Bombyx mori NPV (BmNPV), and Trichoplusia ni MNPV
(TnMNPV), and characterized to encode an inhibitor of
effector caspase, a cysteine protease, that is activated upon
protein cleavage by upstream initiator caspases and func-
tions as the executioner of apoptosis (Clem, 2001; Clem et
al., 1991; Dai et al., 1999; Kamita et al., 1993). Recently,
p49 was identified from Spodoptera littoralis MNPV as a
second member of the p35 family (Du et al., 1999; Pei et al.,
2002). P49 inhibits upstream initiator caspase, in addition to
effector caspase, in the apoptotic pathway (Jabbour et al.,
2002).
In contrast to the genes of the p35 family that are present
only in certain NPVs, iaps are encoded by genomes of all
lepidopteran baculoviruses so far sequenced. Baculovirus
IAPs are currently classified into five members, IAP1–
IAP5, based on amino acid sequence homology (Luque et
al., 2001; Maguire et al., 2000). Functional analyses have
revealed that only IAP3 is capable of blocking apoptosis in
Cydia pomonella granulovirus (CpGV) (Crook et al., 1993;
Vilaplana and O’Reilly, 2003) and Orgyia pseudotsugata
MNPV (OpMNPV) (Birnbaum et al., 1994; Means et al.,
2003), although these viruses possess three and four iaps,
respectively. Whereas only IAP1 and IAP2, but not IAP3
and IAP4, exhibit anti-apoptotic activity in Epiphyas post-
vittana MNPV (EppoMNPV) (Maguire et al., 2000). Al-
Fig. 1. Anti-apoptotic activity of SpIm cells infected with HycuNPV. SpIm
cells were mock-infected (M) or infected with HycuNPV at an MOI of 10
PFU/cell, and at indicated times postinfection (pi), cells were treated with 1
Ag/ml of actinomycin D (ActD) for 24 h. After ActD treatment, cells were
collected and apoptotic DNA fragments were extracted. The apoptotic DNA
fragments were electrophoresed on 1% SeaKem GTG agarose gel
containing EtBr in TBE buffer. 100 base-pair ladder (100 bp) was used
as standard.
M. Ikeda et al. / Virology 321 (2004) 359–371360though it is documented that two baculovirus iap repeat
(BIR) domains in the N-terminal region and a RING finger
motif in the C-terminal region (Birnbaum et al., 1994;
Crook et al., 1993; Miller, 1999; Salvesen and Duckett,
2002) are essential for anti-apoptotic activity of baculovirus
IAPs (Clem and Miller, 1994; Hozak et al., 2000; Huang et
al., 2000; Vucic et al., 1998; Wright and Clem, 2002),
molecular mechanisms underlying blockage of apoptosis
by baculovirus IAPs have not been well defined.
Recently, IAPs have also been identified in lepidopteran
insects that include Tricoplusia ni (Seshagiri et al., 1999),
Spodoptera frugiperda (Huang et al., 2000), and Bombyx
mori (Huang et al., 2001). Phylogenetic analysis suggested
that baculovirus iaps were derived from insect hosts (Huang
et al., 2000; Hughes, 2002). Such analysis further showed
that iap3 of NPV was acquired from the insect host through
a gene capture event that was different from those involved
in the gene capture by a possible ancestor of other NPV
iaps, suggesting that NPV IAPs other than IAP3 might have
been evolved to play functional roles distinct from that of
IAP3 in infected insect cells.
We have previously shown that Ld652Y cells infected
with Hyphantria cunea NPV (HycuNPV) undergo severe
apoptosis, producing no detectable budded virions (BVs)
and polyhedrin (Ishikawa et al., 2003). In the present study,
we show that HycuNPV does not possess the p35 gene
homologue but encodes three iap genes designated as hycu-
iap1, hycu-iap2, and hycu-iap3. Functional analysis of these
iap genes by transient expression assay demonstrates that
only Hycu-IAP3 is capable of blocking apoptosis of Sf9
cells induced by actinomycin D (ActD) and p35-deficient
AcMNPV (AcMNPVDp35). Our results also show that
knockdown of hycu-iap3 expression by hycu-iap3 dsRNA
results in the apoptosis of HycuNPV-infected SpIm cells,
indicating that Hycu-IAP3 is an indispensable anti-apoptotic
protein for HycuNPV productive infection of SpIm cells.Results
Inhibition of ActD-induced apoptosis of SpIm cells by
HycuNPV infection
To examine whether HycuNPV induces anti-apoptotic
activity through infection, SpIm cells were mock-infected or
infected with HycuNPV and at different times postinfection
(pi), cells were treated with ActD for 24 h. The results
showed that almost all the mock-infected cells were broken
into apoptotic bodies, producing apoptotic DNA fragments
(Fig. 1). Apoptotic body formation and apoptotic DNA
fragmentation were also detected in cells treated with ActD
at 0 h pi. On the other hand, HycuNPV-infected cells treated
with ActD at 4 h pi or later did not undergo apoptosis and
showed no apoptotic DNA fragmentation (Fig. 1). These
results indicated that HycuNPV infection induced anti-
apoptotic activity in SpIm cells as early as 4 h pi.Identification and structural analysis of HycuNPV iap genes
To identify anti-apoptotic genes of HycuNPV, HycuNPV
genomic DNA was digested with seven different restriction
enzymes, EcoRI, HindIII, PstI, SacII, SalI, SpeI, and XhoI,
and Southern blot analysis was performed with probes
specific to anti-apoptotic genes including p35 (ac-p35)
and iap1 (ac-iap1) from AcMNPV and iap2, iap3, and
iap4 (op-iap2, op-iap3, and op-iap4, respectively) from
OpMNPV. When blots were probed with ac-p35 or op-
iap4, a positive signal was not detected in HycuNPV
genomic DNA fragments. On the other hand, ac-iap1, op-
iap2, and op-iap3 detected single or divided positive signals
in HycuNPV genomic DNA fragments that had been
digested with any of the restriction enzymes used (data
not shown). When ac-iap1 was used as probe, a 4.7-kbp
PstI H fragment (cf. Kamiya et al., 2003) was detected as a
positive signal. Nucleotide sequencing showed that the PstI
H fragment encoded an HycuNPV homologue of iap1,
hycu-iap1, which composed 828 bp encoding a polypeptide
of 276 amino acids with a predicted molecular mass of 31.4
kDa (Fig. 2A). Hycu-IAP1 shared 81% amino acid sequence
identity to Op-IAP1.
When op-iap2 was used as probe, divided fragments of
3.5 and 1.3 kbp were detected in the SacII-digested
HycuNPV genome. Nucleotide sequencing showed that
Fig. 2. Nucleotide sequences and deduced amino acid sequences of hycu-iap1, hycu-iap2, and hycu-iap3. Underlines indicate the BIR domains, BIR1 and BIR2, and double underline indicates the RING finger
motif. Early promoter motif, TATA box followed by CA(G/T)T, and late promoter motif, (A/T/G)TAAG, were boxed and shaded, respectively.
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M. Ikeda et al. / Virology 321 (2004) 359–371362these fragments encoded a homologue of iap2, hycu-iap2,
that composed 729 bp encoding a polypeptide of 243
amino acids with a predicted molecular mass of 27.3
kDa (Fig. 2B). Hycu-IAP2 shared 71% amino acid se-
quence identity to Op-IAP2.
Similarly, op-iap3 detected a 3.3-kbp HindIII M frag-
ment (cf. Kamiya et al., 2003) that encoded a homologue of
iap3, hycu-iap3. hycu-iap3 composed 789 bp that encoded a
polypeptide of 263 amino acids with a predicted molecular
mass of 30.2 kDa (Fig. 2C). Hycu-IAP3 shared 62% amino
acid sequence identity to Op-IAP3. Hycu-IAP3 also shared
higher identities to functional IAPs, with 55%, 57%, 57%,
and 56% amino acid sequence identities to Cp-IAP3, B.
mori IAP, T. ni IAP, and S. frugiperda IAP, respectively. The
identities between Hycu-IAP1 and Hycu-IAP2, Hycu-IAP1
and Hycu-IAP3, and Hycu-IAP2 and Hycu-IAP3 were 14%,
26%, and 17%, respectively. All these Hycu-IAPs contained
two BIR domains at the N-terminal portion and a RING
finger motif at the C-terminus (Figs. 2 and 3).
hycu-iap expression during HycuNPV infection
The expression of hycu-iap genes in SpIm cells infected
with HycuNPV was examined by Northern blot analysis
(Fig. 4). When hycu-iap1 was used as probe, a 1.5-kb
transcript was first detected at 12 h pi, increased until 36
h pi, and then decreased gradually (Fig. 4A). A similar
expression profile was observed in hycu-iap2, in which a
1.3-kb transcript was first detected at 16 h pi, reached a
maximum level at 48 h pi, and then decreased slightly
(Fig. 4B). When hycu-iap3 was used as probe, 1.4- and
0.9-kb transcripts were first detected at 4 h pi and
increased until 16 h pi (Fig. 4C). At 16 h pi, the signal
of the 0.9-kb transcript determined by BAS2000 imaging
analyzer was twice as strong as that of the 1.4-kb tran-
script. Both transcripts decreased quickly at 24 h pi and
remained at this low level thereafter. The appearance of                
   
   
   
  
  
  
         
       
       
       
Fig. 3. Amino acid sequence alignments of the BIR domains and RING finger m
RING finger motif (B, RING finger) are also presented, in which x denotes any
Numbers of amino acid sequence are indicated on both sides.hycu-iap3 expression at 4 h pi was well correlated with the
appearance of anti-apoptotic activity in HycuNPV-infected
SpIm cells (cf. Fig. 1).
The accumulation of Hycu-IAP proteins in HycuNPV-
infected SpIm cells was examined by immunoblot analysis
using antibodies against Hycu-IAP1, Hycu-IAP2, and
Hycu-IAP3 (Fig. 5). Hycu-IAP1 and Hycu-IAP2 were
identified as 33- and 27.5-kDa proteins, respectively, and
were first detected at 16 h pi, increased to 36 h pi, and then
decreased gradually until 72 h pi (Figs. 5A and B). A
different accumulation pattern was observed in Hycu-
IAP3, in which a 28-kDa protein was first detected at 12
h pi, increased to 16 h pi, decreased slightly to 48 h pi, and
then became barely detectable by 72 h pi (Fig. 5C).
Suppression of ActD-induced apoptosis by Hycu-IAPs
To examine whether the Hycu-IAPs have the ability to
block ActD-induced apoptosis, Sf9 cells were transfected
with pIE/HAhycu-iap1, pIE/HAhycu-iap2, and pIE/
HAhycu-iap3, that expressed Hycu-IAP1, Hycu-IAP2, and
Hycu-IAP3, respectively. To facilitate detection of Hycu-
IAP proteins, HA tag was fused to the N-terminus of each
Hycu-IAP. At 48 h after the transfection, Sf9 cells were
harvested and HA-tagged Hycu-IAPs expressed in the cells
were examined by immunoblot analysis (Fig. 6A). Poly-
peptides of 35, 28, and 34 kDa were detected in cells
transfected with pIE/HAhycu-iap1, pIE/HAhycu-iap2, and
pIE/HAhycu-iap3, respectively, under the control of
AcMNPV ie1 promoter (Fig. 6A). The expression level of
HAHycu-IAP2 was about 50 times lower than those of
HAhycu-IAP1 and HAhycu-IAP3. A minor band of ap-
proximately 41 kDa was also detected in cells transfected
with pIE/HAhycu-iap3. To examine the anti-apoptotic ac-
tivity of these proteins, Sf9 cells transfected with each of
three pIE/HAhycu-iap constructs or pIE/egfp that expressed
EGFP were incubated with ActD for 6 h and the percentage  
  
  
 
 
 
 
 
 
otif of Hycu-IAPs. Consensus sequences in the BIR domain (A, BIR) and
amino acid. Black and gray indicate identity and homology, respectively.
Fig. 5. Immunoblot analysis of Hycu-IAP1, Hycu-IAP2, and Hycu-IAP3 in
SpIm cells infected with HycuNPV. Polypeptides from HycuNPV-infected
SpIm cells at 0, 4, 8, 12, 16, 24, 36, 48, 60, and 72 h pi were separated on
12.5% polyacrylamide gel and blotted onto Immobilon transfer membranes.
Hycu-IAP1 (A), Hycu-IAP2 (B), and Hycu-IAP3 proteins (C) were probed
by antisera against Hycu-IAP1, Hycu-IAP2, and Hycu-IAP3, respectively,
and visualized by goat anti-mouse IgG antibody conjugated with
horseradish peroxidase and ECL. The approximate molecular mass of each
Hycu-IAP is indicated on the right.
M. Ikeda et al. / Virology 321 (2004) 359–371 363of surviving cells was determined by laser scanning cytom-
eter (Fig. 6B). A significantly greater percentage of surviv-
ing cells was observed in the culture transfected with pIE/
HAhycu-iap3 as compared with that in the mock-transfected
culture or those in cultures transfected with pIE/HAhycu-
iap1, pIE/HAhycu-iap2, and pIE/egfp (Fig. 6B). To see if
the anti-apoptotic activity is dependent on the level of Hycu-
IAP3 expression, different amounts (from 0.1 to 8 Ag) of
pIE/HAhycu-iap3 were transfected into Sf9 cells and trans-
fected cells were treated with ActD for 6 h. Immunoblot
analysis showed that the level of Hycu-IAP3 expression
increased with increasing amounts of transfected DNA in a
range from 0.1 to 2 Ag but decreased slightly at 8 Ag (Fig.
7A). The percentage of surviving cells increased with
increasing amount of transfected pIE/HAhycu-iap3 in a
range from 0.1 to 2 Ag, exhibiting maximal apoptosis
inhibition activity at 2 Ag (Fig. 7B).
Rescue of NPV-induced apoptosis by Hycu-IAPs
To see whether Hycu-IAPs have ability to rescue NPV-
induced apoptosis, Sf9 cells were co-transfected with
AcMNPVDp35 DNA and each of pIE/HAhycu-iap1, pIE/
HAhycu-iap2, and pIE/HAhycu-iap3, and transfected Sf9
cells were examined for apoptosis and cytopathology under
a microscope (Fig. 8). When Sf9 cells were transfected with
AcMNPVDp35 DNA only, apoptosis was observed by 24
h post-transfection and most transfected Sf9 cells underwent
apoptosis by 72 h post-transfection (Fig. 8A). A similar
apoptotic response was observed in Sf9 cells co-transfected
with AcMNPVDp35 DNA and pIE/HAhycu-iap2 (Fig. 8C).Fig. 4. Northern blot analysis of hycu-iap1, hycu-iap2, and hycu-iap3 gene
expressions. Total RNA was extracted from HycuNPV-infected SpIm cells
at 0, 4, 6, 8, 12, 16, 24, 36, 48, and 72 h pi and separated on 1.2% agarose-
formaldehyde gel. The RNA on the gel was transferred to a Hybond-N+
membrane and probed with 32P-labeled PCR-products specific for hycu-
iap1 (A), hycu-iap2 (B), and hycu-iap3 (C). Molecular sizes of hycu-iap1,
hycu-iap2, and hycu-iap3 mRNAs are indicated on the right, and molecular
size markers on the left.
Fig. 6. Transient expression and anti-apoptotic activity of Hycu-IAPs in Sf9
cells. (A) Two micrograms of pIE/HAhycu-iap1 (1), pIE/HAhycu-iap2 (2),
pIE/HAhycu-iap3 (3), and pIE/egfp plasmids (E) were each transfected into
Sf9 cells. At 48 h post-transfection, HA-tagged polypeptides expressed in
transfected cells were examined by immunoblot analysis with anti-HA
monoclonal antibody. Expression in mock-transfected Sf9 cells (C) is also
presented. Numbers on the left of the panel indicate molecular masses of
molecular size marker proteins (BenchMark). (B) At 48 h post-transfection,
transfected cultures were treated with ActD (0.5 Ag/ml) for 6 h and these
cells were processed for laser scanning cytometry analysis. Anti-apoptotic
activity was expressed as the percentage of surviving cells that was
determined by dividing the number of viable cells in ActD-treated culture
with the number of viable cells in culture without ActD treatment. Vertical
bars represent standard deviations of averages from three independent
determinations. C, mock-transfected cells.
Fig. 7. Dose-dependent expression and anti-apoptotic activity of Hycu-
IAP3 in Sf9 cells. (A) Sf9 cells were cotransfected with indicated amounts
of pIE/HAhycu-iap3 (hycu-iap3) and 2 Ag of pIE/egfp plasmids (egfp). At
48 h post-transfection, HA-tagged Hycu-IAP3 expressed in Sf9 cells was
examined by immunoblot analysis with anti-HA monoclonal antibody. (B)
At 48 h post-transfection, transfected cultures were treated with ActD for 6
h and these cells were processed for laser scanning cytometry analysis.
Anti-apoptotic activity was expressed as the percentage of surviving cells
that was determined by dividing the number of viable cells in ActD-treated
culture with the number of viable cells in culture without ActD treatment.
Numbers on the left of panel A indicate molecular masses of molecular size
marker proteins (BenchMark). For details, see legend to Fig. 6.
M. Ikeda et al. / Virology 3364In the culture co-transfected with AcMNPVDp35 DNA and
pIE/HAhycu-iap1, a few growing cells besides apoptotic
cells were observed at 72 h (Fig. 8B), but most cells
underwent apoptosis by 96 h (data not shown). No detect-
able production of polyhedra was observed in cells under-
going apoptosis that had been co-transfected with
AcMNPVDp35 DNA and pIE/HAhycu-iap1 or pIE/
HAhycu-iap2. In contrast, in the culture co-transfected with
AcMNPVDp35 and pIE/HAhycu-iap3, less than 1% of cells
underwent apoptosis and approximately 30% of cells pro-
duced polyhedra by 72 h (Fig. 8D), and the number of cells
producing polyhedra increased at 96 h. These results indi-
cated that Hycu-IAP3 was capable of blocking apoptosis of
Sf9 cells induced by AcMNPVDp35.Knockdown of hycu-iap3 expression during HycuNPV
infection
To examine if the anti-apoptotic activity of Hycu-IAP3 is
essential for productive infection of HycuNPV in SpIm
cells, knockdown of hycu-iap3 expression was carried out
by hycu-iap3 dsRNA. The effect of hycu-iap3 dsRNA on
hycu-iap3 expression was first examined in Sf9IAP3 cell line
that stably expressed HA-tagged Hycu-IAP3. Sf9IAP3 cells
were transfected with 0.5, 2, and 5 Ag of hycu-iap3 dsRNA
and at 3 days post-transfection, the cells were examined for
Hycu-IAP3 expression by immunoblot analysis. The results
showed that hycu-iap3 dsRNA strikingly reduced Hycu-
21 (2004) 359–371
Fig. 8. Rescue of AcMNPVDp35 replication by Hycu-IAP3 in Sf9 cells.
Sf9 cells were co-transfected with 1 Ag of AcMNPVDp35 genomic DNA
and 2 Ag of pIE/HAhycu-iap1 (B), pIE/HAhycu-iap2 (C), or pIE/HAhycu-
iap3 plasmid (D) and incubated for 72 h. Mock-transfected cells (E) and
cells transfected with AcMNPVDp35 DNA alone (A) were also
incorporated into the figure for comparison. Polyhedron formation was
indicated on the right.
Fig. 9. Specificity of RNAi in SfIAP3 and SpIm cells. (A) SfIAP3 cells were
transfected with indicated amounts of hycu-iap3 dsRNA, and at 72 h post-
transfection, transfected cells were collected and HA-tagged Hycu-IAP3
expression was examined by immunoblot analysis with anti-HA monoclo-
nal antibody. Molecular size markers (BenchMark) are indicated on the left.
(B) SpIm cells were co-transfected with 2 Ag of pHyHr6IE1/Luc and
indicated amounts of luciferase dsRNA or hycu-iap3 dsRNA. At 72 h post-
transfection, cells were collected and luciferase activity was determined by
using Bright-Glo luciferase assay system. Luciferase activity was expressed
relative (%) to the activity in cells transfected with pHyHr6IE1/Luc alone.
Vertical bars represent standard deviations of averages from three
independent determinations.
M. Ikeda et al. / Virology 321 (2004) 359–371 365IAP3 expression to a negligible level even in cells trans-
fected with 0.5 Ag of hycu-iap3 dsRNA (Fig. 9A). To
examine whether dsRNA-dependent RNAi performs suc-
cessfully in SpIm cells as well, 2 Ag of plasmid encoding
luciferase, pHyHr6IE1/Luc, was co-transfected with 0.5, 2,
or 10 Ag of luciferase dsRNA, and the co-transfected SpIm
cells were incubated for 2 days. The cell extracts showed
that luciferase dsRNA reduced luciferase activity in a dose-
dependent manner, while hycu-iap3 dsRNA used as anegative control did not reduce the luciferase activity at
all (Fig. 9B). These results suggested that hycu-iap3 dsRNA
could be used to suppress Hycu-IAP3 expression in SpIm
cells infected with HycuNPV.
To examine whether suppression of hycu-iap3 expression
during HycuNPV infection induced apoptosis of HycuNPV-
infected SpIm cells, the cells co-transfected with HycuNPV
DNA and hycu-iap3 dsRNA were examined under a micro-
scope. Most of the co-transfected SpIm cells formed apo-
ptotic bodies at 5 days post-transfection (Fig. 10Ac). In
contrast, apoptotic bodies were observed in few, if any, cells
when transfected with HycuNPV DNA alone (Fig. 10Ae) or
co-transfected with HycuNPV DNA and each of hycu-iap1
Fig. 10. Effect of hycu-iap3 dsRNA on HycuNPV transfection and caspase-3-like protease activity of SpIm cells. (A) SpIm cells were co-transfected with 1 Ag
of HycuNPV genomic DNA and 10 Ag of dsRNA against hycu-iap1 (a), hycu-iap2 (b), hycu-iap3 (c), and luciferase (d) and incubated for 5 days. Mock-
transfected cells (f) and cells transfected with 1 Ag of HycuNPV genomic DNA alone (e) are also presented. (B) At 5 days post-transfection, cells were
collected and DEVD-cleavage activity was analyzed by using ApoProbe-3. DEVD-cleavage activity was expressed as arbitrary units. Vertical bars represent
standard deviations of averages from three independent determinations.
M. Ikeda et al. / Virology 321 (2004) 359–371366dsRNA, hycu-iap2 dsRNA, or luciferase dsRNA (Figs.
10Aa, b, d). The DEVD-cleavage activity assay in trans-
fected cells showed that caspase-3-like protease activity
increased significantly only in SpIm cells co-transfected
with HycuNPV DNA and hycu-iap3 dsRNA (Fig. 10B),
suggesting that apoptosis of HycuNPV-infected SpIm cells
induced by knockdown of hycu-iap3 expression by hycu-
iap3 dsRNA was associated with activation of caspase-3-
like protease.Discussion
In this study, we have focused on HycuNPV anti-apo-
ptotic genes and demonstrated that HycuNPV contains
homologues of three members of iap. These three
HycuNPV iap homologues were designated as hycu-iap1,hycu-iap2, and hycu-iap3 because of their amino acid
sequence homology with other iaps identified previously
in CpGV (Crook et al., 1993), AcMNPV (Clem and Miller,
1994), OpMNPV (Birnbaum et al., 1994), and EppoMNPV
(Maguire et al., 2000). Hycu-IAP1, Hycu-IAP2, and Hycu-
IAP3 showed the highest homology with corresponding
OpMNPV IAPs, exhibiting 81%, 71%, and 62% amino
acid sequence identities with Op-IAP1, Op-IAP2, and Op-
IAP3, respectively. Such high identity between HycuNPV
and OpMNPV observed IAPs is consistent with the results
of other viral proteins including GP64 and PCNA (Felipe
Alves et al., 2002a; Iwahori et al., 2002). Like other
baculovirus IAPs, Hycu-IAPs possess two BIR domains in
the N-terminal region and a single RING finger motif in the
C-terminal region. In the promoter region, along with one
TATA box, hycu-iap3 has both early and late transcription
initiator motifs, whereas only late transcription initiator
M. Ikeda et al. / Virology 321 (2004) 359–371 367motif is found in hycu-iap1 and hycu-iap2. Consistent with
such promoter organization, our results from analyses by
Northern blotting and immunoblotting showed that expres-
sion of hycu-iap3 initiated earlier after infection than
expressions of hycu-iap1 and hycu-iap2 in the HycuNPV-
infected SpIm cells.
In accordance with the results in OpMNPV (Means et al.,
2003), our results from RNAi assays showed that knock-
down of hycu-iap3 expression induced apoptosis of
HycuNPV DNA-transfected SpIm cells, while introduction
of dsRNAs against hycu-iap1 and hycu-iap2 into HycuNPV
DNA-transfected SpIm cells did not trigger apoptosis. These
results indicate that hycu-iap3 is indispensable for
HycuNPV to resist apoptosis induction to maximize the
yield of progeny virions in conventional host SpIm cells. In
addition, our results from transient expression assays in Sf9
cells revealed that Hycu-IAP3 blocked apoptosis induced
not only by ActD but also by infection with p35-deficient
AcMNPV, AcMNPVDp35, while Hycu-IAP1 and Hycu-
IAP2 exhibited no detectable anti-apoptotic activity. Taken
together, such functional analyses of Hycu-IAPs indicate
that only hycu-iap3 encodes functional anti-apoptotic pro-
tein while hycu-iap1 and hycu-iap2 code for proteins not
functional in blocking apoptosis. It is thus probable that the
anti-apoptotic activity presented in this study in HycuNPV-
infected SpIm cells is attributed to hycu-iap3.
Our results showed that neither Hycu-IAP1 nor Hycu-
IAP2 was capable of blocking apoptosis of Sf9 cells
induced by ActD and AcMNPVDp35. In a preliminary
study, we have found that expression of Hycu-IAP1 in
AcMNPVDp35 DNA-transfected Sf9 cells significantly
increased the extent of apoptosis induction up to 24
h post-transfection compared with that of Sf9 cells trans-
fected with AcMNPVDp35 DNA alone (data not shown).
In addition, recent studies in our laboratory have shown
that overexpression of Hycu-IAP1 alone induces apoptosis
in a significant number of cells in culture of several
different insect cell lines, including Sf9, Ld652Y, TN368,
and Drosophila S2 (Ikeda, unpublished). While apoptosis-
inducing activity has not been reported for full-length IAPs
so far identified, portions of baculovirus IAP sequences
that include BIR domains of Op-IAP3 and Cp-IAP3, or
RING finger motif of Cp-IAP3 have been shown to trigger
apoptosis of Sf21 cells (Harvey et al., 1997). Furthermore,
it has been shown that truncated Op-IAP3 protein defective
in RING finger motif sequence sensitizes Sf21 cells to
apoptosis induction (Hozak et al., 2000). Because Hycu-
IAP1 is expressed only late in HycuNPV infection of SpIm
cells, it is possible that Hycu-IAP1 induces apoptosis late
in infection. This may facilitate cell-to-cell dissemination
of progeny virions within an individual insect (Alnemri et
al., 1992; Teodoro and Branton, 1997). Such speculation is
consistent with the previous suggestion that apoptosis
induced by NPV infection could be triggered by late events
as well as early events of virus infection (LaCount and
Friesen, 1997).Our results showed that the amount of Hycu-IAP2
accumulated in Sf9 cells transfected with pIE/HAhycu-
iap2 was about 50 times lower than those of Hycu-IAP1
and Hycu-IAP3 accumulated after transfection with pIE/
HAhycu-iap1 and pIE/HAhycu-iap3, respectively. Because
expression from these three plasmids is driven by the same
AcMNPV ie1 promoter, it is likely that the Hycu-IAP2
protein is less stable and degraded more quickly compared
with Hycu-IAP1 and Hycu-IAP3 proteins. It was recently
demonstrated that BmNPV IAP2 (Bm-IAP2) with a RING
finger motif functions as ubiquitin ligase (RING E3) that is
able to be ubiquitinated by itself in in vitro ubiquitination
assay (Imai et al., 2003). The RING finger motif of Bm-
IAP2 was very similar to that of Hycu-IAP2 and shared 83%
amino acid sequence identity. Thus, it is possible that Hycu-
IAP2 has ubiquitin ligase activity. Hycu-IAP2 may catalyze
autoubiquitination and ubiquitinated Hycu-IAP2 is elimi-
nated by a ubiquitin-dependent degradation system (Pickart,
2001).
Our results in this study together with the results from
P35 of AcMNPV (Clem et al., 1991) and Op-IAP3 of
OpMNPV (Means et al., 2003) provide evidence that the
presence of anti-apoptotic proteins is essential to circum-
vent cellular apoptosis induction and to optimize baculo-
virus multiplication in permissive host cells. In addition,
we have suggested that certain baculovirus IAPs potential-
ly have functional roles during baculovirus infection that
are distinct from those of anti-apoptotic proteins. Further
analyses to address these issues are currently in progress in
our laboratory using various cell lines infected with a
variety of NPV species.Materials and methods
Viruses, cells, and infection
Plaque-purified NPV clones from H. cunea (HycuNPV
N9; Kamiya et al., 2003), A. californica (AcMNPV E2;
Smith and Summers, 1978), and O. pseudotsugata
(OpMNPV; Bradford et al., 1990; Quant-Russell et al.,
1987) were used. A mutant AcMNPV defective in p35,
vP35delBsu36Igus (AcMNPVDp35), was obtained from Dr.
Rollie J. Clem (Kansas State University, Manhattan, KS).
FRI-SpIm-1229 (SpIm) cells derived from Spilosoma
imparilis (Mitsuhashi and Inoue, 1988) were grown in
monolayer culture in MM medium (Mitsuhashi and Mar-
amorosch, 1964) supplemented with 3% fetal bovine serum
(FBS). Sf9 cells derived from S. frugiperda were maintained
in Grace’s medium (Invitrogen, Carlsbad, CA) supple-
mented with 10% FBS. Unless otherwise stated, monolayer
cultures of these cells were infected with viruses at an input
multiplicity of infection (MOI) of 5 plaque-forming units
(PFU) per cell. After a 60-min adsorption period at room
temperature, the inoculum was replaced by appropriate fresh
medium and incubated at 28 jC.
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Actinomycin D (ActD) stock solution (5 mg/ml) was
prepared and diluted in appropriate culture media to desired
concentrations before used. SpIm cells (1  106) in 12.5-
mm2 flasks (Falcon 3018; Becton Dickinson Labware,
Franklin Lakes, NJ) were mock-infected or infected with
HycuNPV at an MOI of 10 PFU per cell and at different
times postinfection (pi). These cells were treated with 2 ml
of ActD at a concentration of 1 Ag/ml for 24 h at 28 jC. Sf9
cells (1  106) in 35-mm dishes (Falcon 3001) were trans-
fected with plasmid DNAs, and at 48 h post-transfection,
they were treated with 1 ml of ActD at 0.5 Ag/ml at 28 jC
for 6 h.
ActD-treated cells were collected by low-speed centrifu-
gation and washed with PBS (2.7 mM KCl, 1.5 mM
KH2PO4, 137 mM NaCl, 8 mM Na2HPO4). Apoptotic
DNA fragments in ActD-treated cells were extracted in
NP40 lysis buffer (1% NP40, 20 mM EDTA, 50 mM
Tris–HCl, pH 7.5) and analyzed by a 1% SeaKem GTG
agarose (FMC BioProducts, Rockland, ME) gel as described
previously (Ishikawa et al., 2003). 100 base-pair Ladder
(Amersham Biosciences Corp., Piscataway, NJ) was used as
DNA size marker.
Laser scanning cytometry analysis
To determine the percentage of surviving cells after
ActD-treatment, laser scanning cytometry analysis was
carried out. Two sets of parallel cell cultures were trans-
fected with the plasmid construct of interest, and at different
times after the transfection, one culture received ActD
treatment while the other culture was not treated with ActD.
The cells with or without ActD treatment were scraped by
rubber policeman and seeded on a collagenized cover glass
(Collagen type I-coated cover glass, Iwaki, Tokyo, Japan).
These cells were then washed with PBS containing 1 mM
CaCl2 and 1 mM MgCl2 (PBS(+)) and fixed with 2%
paraformaldehyde in PBS(+) for 10 min. The fixed cells
were incubated for 30 min at 37 jC with propidium iodide
(50 Ag/ml PBS) containing RNase A (200 Ag/ml), mounted
with Vectashield mounting medium (Vector Laboratories
Inc., Burlingame, CA), and covered with a slide glass.
The viable cells stained with propidium iodide were counted
in three different areas of 2  2 mm (>2000 cells) from
cultures with or without ActD treatment by laser scanning
cytometer (LSC101, Olympus, Tokyo, Japan) and the per-
centage of survival cells that resisted apoptosis was deter-
mined by dividing the number of viable cells from ActD-
treated culture by those from the parallel culture without
ActD treatment.
Viral DNA isolation and Southern blot analysis
HycuNPV genomic DNAwas extracted from HycuNPV-
infected SpIm cells as described previously (Lavin˜a et al.,
M. Ikeda et al. / Viro3682000). Viral DNA (1–2 Ag) was digested with restriction
endonucleases and DNA fragments produced were separated
on 0.8% SeaKem GTG agarose gel. The DNA fragments on
the gel were blotted onto a Hybond-N+ nylon membrane
(Amersham Biosciences Corp.) and hybridized with probes.
p35 and iap1 of AcMNPV (ac-p35 and ac-iap1, respective-
ly) and iap2, iap3, and iap4 of OpMNPV (op-iap2, op-iap3,
and op-iap4, respectively) were PCR-amplified using
AcMNPV or OpMNPV genome DNA as the template and
speci f ic pai red pr imers : 5V-CCGGTAGAAATC-
GACGTGTC-3Vand 5V-GCCCCAGCTCGATTCTGTAG-3V
for ac-p35; 5V-CGTGTGTGACAACTTTCGCG-3V and
5V-CGGTTGACGTCCTGACGACAC-3V for ac-iap1; 5V-
CACGATGTCCTTCATGTCGC-3V and 5V-TTGAGG-
GATGGTGCTGAGGC-3V for op-iap2; 5V-TGAGCTCCC-
G A G C A AT T G G C - 3 V a n d 5 V- C T T G G TA C
ATGCGCACCGCT-3V for op-iap3; and 5V-AAAGGT-
GAACGGCAGGCTGC-3V and 5V-GCCTATGCGA-
TAACTGCACG-3V for op-iap4. PCR products were
labeled with Gene Images random prime labeling module
(Amersham Biosciences Corp.). Hybridized DNA fragments
were processed by Gene Images CDP-Star detection module
(Amersham Biosciences Corp.) and visualized by exposing
onto X-ray films (Fuji Photo Film, Tokyo, Japan).
DNA cloning and sequencing
Viral DNA fragments were subcloned into pBluescript
KS (+) (pBS; Stratagene, La Jolla, CA) and transformed
into XL1-blue (Stratagene). The plasmid DNA was
extracted by Flexiprep DNA purification kit (Amersham
Biosciences Corp.) and used for the sequence reaction by
Big Dye terminator sequencing reaction mix (Applied
Biosystems, Foster City, CA) according to the manufac-
turer’s protocol. The nucleotide sequence was determined
by ABI PRISM 310 genetic analyzer (Applied Biosys-
tems) and connected by DNASIS (Hitachi, Yokohama,
Japan).
RNA isolation and Northern blot analysis
Total RNA was isolated from virus-infected cells with
TRIzol reagent (Invitrogen) according to the manufactur-
er’s instruction and dissolved in 0.5% SDS. The RNA
samples (20 Ag/lane) were denatured, electrophoresed in
1.2% agarose gel (4% formaldehyde, 100 mM MOPS, 25
mM CH3COONa, 5 mM EDTA), and blotted onto a
Hybond-N+ nylon membrane (Amersham Biosciences
Corp.) in 5 mM NaOH as described previously (Ishikawa
et al., 2003). The RNA on the membrane was hybridized
with specific probes that were labeled with [a-32P]dCTP
(NEN Life Science Products, Boston, MA) by the redi-
prime random prime labeling system (Amersham Bioscien-
ces Corp.). The probe DNAs used for 32P-labeling were
prepared by PCR using HycuNPV genomic DNA as
template and three paired primers: hycu-iap1, sense primer
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primer 72–91 and antisense primer 705–724; hycu-iap3,
sense primer 5–24 and antisense primer 743–762 (hycu-
iaps nucleotide numbers, see Fig. 2). Hybridized probes
were visualized by a BAS 2000 imaging analyzer (Fuji
Photo Film).
Plasmids
pIE/HAhycu-iap1, pIE/HAhycu-iap2, and pIE/HAhycu-
iap3 used in transient expression assay were constructed
by inserting PCR-amplified hemaglutinine (HA)-tagged
hycu-iap genes into BamHI–NotI sites of the pIE1-2
(Novagen, Darmstadt, Germany). HA-tagged hycu-iap1,
hycu-iap2, and hycu-iap3 were amplified by using pHyH-
r6IE1/HAhycu-iap1, pHyHr6IE1/HAhycu-iap2, and
pHyHr6IE1/HAhycu-iap3 as the templates, respectively,
and 5V-GGATCCCATGTACCCATACGA-3V and 5V-
GTCTGCTCGAAGCGGGCGGC-3V as a 5V primer and a
3V primer, respectively. pHyHr6IE1/HAhycu-iap1, pHyH-
r6IE1/HAhycu-iap2, and pHyHr6IE1/HAhycu-iap3 were
constructed from pHyHr6IE1/Luc (Felipe Alves et al.,
2002b) by replacing the luciferase ORF within NcoI–
XbaI sites with ORFs of hycu-iap1, hycu-iap2, and hycu-
iap3, respectively. The ORFs of hycu-iap1, hycu-iap2,
and hycu-iap3 were amplified by PCR using HycuNPV
genomic DNA as a template and paired primers with
NcoI, SpeI, and XbaI restriction sites (underlined);
Hciap1F (5V-ACTGACACCATGG ACGCGCC-3V) and
Hciap1R (5V-TTGCAACTAGTTCATACCAC-3V); Hciap2F
(5V-GCAATTAACCATGGATTTGC-3V) and Hciap2R (5V-
GTGGTCTAGA CTTATTACTG-3V); and Hciap3F (5V-
GTGTTACCATGGACGCACAC-3V) and Hciap3R (5V-
CTCGTCTAGATTAATAATAC-3V), respectively. For the
addition of HA tag at the N-terminus of Hycu-IAPs, a
NcoI adapter with HA tag was constructed by annealing
5V-CATGGTAGCGTAATCCGGAACATCGTATGGGTA-
3Vand 5V-CATGTACCCATACGATGTTCCGGATTACGC-
TAC-3V that contained translation initiation codon (under-
lined). The NcoI adapter with HA tag was inserted into
the NcoI site of each pHyHr6IE1/hycu-iap plasmid.
pIE/egfp was constructed by inserting the egfp gene into
BamHI–NotI sites of pIE1-2. The egfp gene was prepared
by digesting pBac[3xP3-EGFPafm] (Horn and Wimmer,
2000) with BamHI and NotI.
pIZhycu-iap3 was constructed by inserting hycu-iap3
into NcoI–XbaI sites of pIZ/V5-His (Invitrogen). NcoI
adapter with HA tag was inserted at the NcoI site of the
N-terminal of hycu-iap3 gene. The hycu-iap3 was derived
upon digestion of pHyHr6IE1/HAhycu-iap3 with NcoI and
XbaI
All plasmid constructs were transformed into XL1-blue
(Stratagene). The plasmid DNAs were isolated by Midi
prep kit (Qiagen, Hilden, Germany) or Geno pure plas-
mid midi kit (Roche Diagnostics GmbH, Mannheim,
Germany).Preparation of stably expressing cell lines
For selecting cells stably expressing Hycu-IAP3, Sf9
cells were transfected with pIZhycu-iap3 and incubated in
medium containing 0.2 mg/ml of Zeocin (Invitrogen). A
stably expressing clonal cell line, SfIAP3, was isolated
according to the method described in the manufacturer’s
protocol.
Immunoblot analysis
Polypeptides from infected or transfected cells were
resolved by SDS-polyacrylamide gel electrophoresis
according to the method of Laemmli (1970) and transferred
onto an Immobilon transfer membrane (Millipore, Bedford,
MA) or a nitrocellulose membrane (Advantec Toyo, Tokyo,
Japan) with the aid of Horizblot (Atto, Tokyo, Japan) for 90
min at 200 mA as described previously (Lavin˜a et al., 2000).
The blots were probed with antibodies against HA, Hycu-
IAP1, Hycu-IAP2, and Hycu-IAP3 and reacted with goat
anti-mouse IgG antibody conjugated with horseradish per-
oxidase (Zymed Laboratories, San Francisco, CA). Positive
signals were visualized by ECL (Amersham Biosciences
Corp.). BenchMark pre-stained protein ladder (Invitrogen)
was used as protein size marker.
Anti-HA monoclonal antibody HA.11 was purchased
from Babco (Richmond, CA). The antibodies against
Hycu-IAP1, Hycu-IAP2, and Hycu-IAP3 were raised in
mouse as described previously (Ishikawa et al., 2003) using
portions of each Hycu-IAP protein generated by pET-32b(+)
expression vector (Novagen). For the construction of vec-
tors expressing Hycu-IAP1, Hycu-IAP2, and Hycu-IAP3
proteins, three sets of paired primers with HindIII and XhoI
restriction sites (underlined); 5V-CGGGATCC CGTGAT-
CAATATATGTGC-3Vand 5V-CCGCTCGAGCGGATCTTT-
GAAGGT-3V; 5V-CGGGATCCCGTGGATTTGCAA-3Vand
5V-CCGCTCGAG CGGCAAGGTGTTTATG-3V; and 5V-
CGGGATCC CGGAGTTAACATGGAA-3V and 5V-
CGGCTCGAG CGGGTAATAAAACCC-3, respectively,
were used.
dsRNA production and RNAi procedure
dsRNAs of hycu-iap and luciferase genes were prepared
as described previously (Clemens et al., 2000). Briefly, 631
bp of hycu-iap1, 607 bp of hycu-iap2, 674 bp of hycu-iap3,
and 677 bp of luciferase were amplified by PCR using pIE1/
HAhycu-iap1, pIE1/HAhycu-iap2, pIE1/HAhycu-iap3, and
pGL-Basic vector (Promega, Madison, WI) as the templates,
respectively, and four pairs of PCR primers that contained a
5V T7 RNA polymerase binding site (GAATTAATAC-
GACTCACTATAGGGAGA) followed by sequences spe-
cific for the target genes. Target gene specific primer
sequences were as follows: hycu-iap1, sense primer 42–
56 and antisense primer 658–672; hycu-iap2, sense primer
35–49 and antisense primer 627–641; hycu-iap3, sense
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nucleotide numbers, see Fig. 2); luciferase in the pGL3-
Basic vector, sense primer 122–136 and antisense primer
784–798. PCR products were purified by using Quick spin
column G-50 (Roche Diagnostics GmbH). Sense and anti-
sense RNAs were transcribed by using purified PCR prod-
ucts as templates and Megascript T7 transcription kit
(Ambion, Austin, TX), and annealed by incubation at 65
jC for 30 min, followed by slow cooling at room temper-
ature. dsRNAs were introduced into cells by transfection
(Katou et al., 2001).
Transfection and assay of luciferase and caspase-3-like
protease activities
Transfection was performed in cells (1  106) in 35-mm
tissue culture dishes (Falcon 3001) with indicated amounts
of plasmid DNA or the mixture of 2 Ag of plasmid DNA and
1 Ag of NPV DNA by using 10 Al of Lipofectin (Invitrogen)
as described previously (Katou et al., 2001).
Luciferase activity was determined by using Bright-Glo
luciferase assay system (Promega) as described previously
(Felipe Alves et al., 2002b). Caspase-3-like protease activity
was assayed by using caspase-3 fluorescent assay kit,
ApoProbe-3 (BioDynamics Laboratory Inc., Tokyo, Japan)
as described previously (Ishikawa et al., 2003).Acknowledgments
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